(Dec. 8) Pfizer Inc. and BioNTech SE said initial lab studies show a third dose of their Covid-19 vaccine may be needed to neutralize the omicron variant, results that will accelerate booster-shot drives around the world.
—
Subscribe to our…
LIVE: Bloomberg Quicktake Latest News for December 8
0 Comments
Most Voted